首页 | 本学科首页   官方微博 | 高级检索  
检索        

舒林酸食道支架放疗联合治疗食道癌48例分析
引用本文:陆华生,钱俊波,陈天敏,王高仁,缪旭东.舒林酸食道支架放疗联合治疗食道癌48例分析[J].中国内镜杂志,2003,9(5):11-12.
作者姓名:陆华生  钱俊波  陈天敏  王高仁  缪旭东
作者单位:1. 南通医学院二附院消化内科,226001
2. 南通医学院二附院放疗科,226001
摘    要:目的:探讨一种既能改善食道癌性狭窄所致的吞咽困难,又能抑制肿瘤生长的治疗手段。方法:在1996-1999年期间,采用舒林酸(sulindac)、支架、放疗26例患者,与同期间硒宝康、支架、放疗22例患者进行对照观察,比较两组的吞咽困难积分改善情况和3年存活率。结果:舒林改组与硒宝康组吞咽困难积分无显著差异(P>0.05),3年生存率分别为46.5%和22.7%。P<0.05有显著差异。结论:舒林酸、支架、放疗对晚期食管癌治疗具有较多好疗效,既改善了吞咽困难,又控制肿瘤细胞生长,达到标本兼治的作用。

关 键 词:舒林酸  食管癌  食道支架  放射治疗
修稿时间:2002年11月18

ANALYSIS OF 48 CASES OF ESOPHAGEAL CANCER TREATED BY SULINDAC STENTS COMBINED RADIOTHERAPY
Lu Huasheng,Qian Junbo,Chen Tianmin,et al..ANALYSIS OF 48 CASES OF ESOPHAGEAL CANCER TREATED BY SULINDAC STENTS COMBINED RADIOTHERAPY[J].China Journal of Endoscopy,2003,9(5):11-12.
Authors:Lu Huasheng  Qian Junbo  Chen Tianmin  
Institution:Lu Huasheng,Qian Junbo,Chen Tianmin,et al. Department of Gastroenterology,the Second Affiliated Hospital of Nantong Medical College,Nantong 226001
Abstract:Objective: To explore a way of treatment that not only improve the dysphagia and strictures of esophageal cancer but also inhibit the tumour cells growth.Methods: From 1996 to 2000,twenty-six patients were treated with Sulindac,metallic stent and radiotherapy.Twenty-two patients as control group did placebo,metallic stent and radiotherapy. The 3-year surival rate and the dysphagia improved index were analysised in two groups.Results:The 3-year surival rate was significantly higher in Sulindac group than in control group,being 46.5% and 22.7% respectively( P <0.05).The dysphagia index in two groups was no differentiation( P >0.05).Conclusion: Combined with Sulindac, metallic stent and radiotherapy is good choice for non surgery esophageal cancer.
Keywords:Sulindac  Esophageal  Cancer  Stents  Radiotherapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号